Related Experiment Videos

[Nuclear receptors in the pathophysiology of endocrine tumors]

Hirotaka Shibata1

  • 1Health Center, Department of Internal Medicine, School of Medicine, Keio University.

Insights

Nuclear orphan receptors COUP-TF and DAX-1 regulate SF-1 activity, impacting steroidogenic gene expression. Their altered levels in adrenal tumors suggest a role in tumor development and differential gene regulation.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Context:

  • Steroidogenic factor 1 (SF-1) is a key regulator of steroidogenic cytochrome P-450 genes.
  • Nuclear orphan receptors COUP-TF and DAX-1 are known negative regulators of SF-1 transcriptional activity.
  • Adrenocortical adenomas exhibit altered expression of these nuclear receptors and SF-1 target genes, such as CYP17.

Purpose:

  • To investigate the roles of COUP-TF and DAX-1 in regulating SF-1 activity in the context of endocrine tumors.
  • To correlate the expression levels of COUP-TF, DAX-1, and SF-1 with specific types of adrenocortical adenomas and their gene expression profiles.
  • To explore the potential involvement of these nuclear receptors in the pathogenesis of pituitary adenomas.

Summary:

  • Expression of COUP-TF and DAX-1 is decreased in cortisol-producing adenomas with high CYP17, while increased DAX-1 and decreased SF-1 are observed in deoxycorticosterone-producing adenomas with low CYP17.
  • These findings suggest that DAX-1 and/or COUP-TF may repress CYP17 expression in adrenocortical tumors.
  • SF-1 is also present in pituitary gonadotrophs and gonadotrophic adenomas, where its expression correlates with luteinizing hormone (LH) secretion, indicating a broader role in endocrine regulation.

Impact:

  • Provides insights into the molecular mechanisms underlying different types of adrenocortical adenomas.
  • Highlights the potential of DAX-1 and COUP-TF as therapeutic targets in endocrine tumorigenesis.
  • Suggests that the interplay between SF-1, DAX-1, and COUP-TF is crucial for regulating SF-1 target genes in various endocrine tumors, including pituitary adenomas.

Related Concept Videos